Realities Remixed

Life sciences are at a turning point, where scientific innovation, regulatory pressure, and patient expectations collide with unprecedented advances in data, AI, and digital platforms. IT is no longer a supporting function but a critical driver of how therapies are discovered, developed, scaled, and delivered safely and at speed.
This week, Dave and Rob wrap up our State of Life Sciences mini-series with Thorsten Rall, Global Industry Lead for Life Sciences at Capgemini and together, they connect the dots across the series, exploring how AI, data and innovation are accelerating drug discovery, transforming med tech, modernising manufacturing and improving patient outcomes, all built on a strong digital foundation.
 
TLDR
00:27 – Introduction and conclusion of the Life Sciences mini-series
02:16 – Key insights and lessons from the previous episodes on the Life Sciences landscape
21:18 – Building resilient, efficient and future-ready operations
34:35 – Creating integrated, patient-centric healthcare experiences
43:15 – Why the Digital Core is the foundation for transformation and innovation
53:21 – Final reflections: the future of Life Sciences and the key takeaways
54:53 – Weekend BBQs, Thorsten's daughter's theatre performance, and the role of R&D
 
Hosts
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/
Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/
with co-host Thorsten Rall: https://www.linkedin.com/in/thorsten-alexander-rall-b232185/
 
Production
Marcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
 
Sound
Ben Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/
Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/
 
'Realities Remixed' is an original podcast from Capgemini

Life sciences are at a critical inflection point, where scientific innovation, regulatory demands, and patient expectations converge with advances in data and artificial intelligence, positioning IT as a central driver of faster and more effective drug discovery and clinical development.
This week, Dave and Rob continue with part 3 off the Life Sciences mini-series with Predrag Angelovski, VP, CTO at Healthcare Informatics at Philips to exploring how MedTech products are more and more becoming connected platforms, combining hardware, software and services.

TLDR
00:21 – Introduction with co-host Thorsten Rall
01:00 – Hang out: Esmee joins and Rob is lost at a train station
03:00 – Dig in: Life Sciences mini-series, Part 3
04:57 – Conversation with Predrag Angelovski
50:56 – Travelling to Europe, agents vs. agentic, and the age of intelligence
 
Guest
Predrag Angelovski: https://www.linkedin.com/in/predrag-angelovski/
 
Hosts
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/
Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/
 
Production
Marcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
 
Sound
Ben Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/
Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/
 
'Realities Remixed' is an original podcast from Capgemini

Resilience is the recognition that in today’s highly interconnected and unpredictable world, disruption cannot always be anticipated or prevented and therefore requires a shift from traditional risk avoidance toward designing systems that can absorb shocks, adapt in real time, and recover quickly, ultimately emerging stronger and turning uncertainty into a source of advantage.
This week, Dave, Esmee, and Rob are joined by Benjamin Trump, President Society for Risk Analysis and Cedrick Moriggi, Chief Resilience Officer and co-found the CCRO network under the United Nations Office for Disaster Risk Reduction, to explore what resilience means in a world shaped by systemic risk, fragile supply chains, climate shocks, cyber threats and human decision-making.
 
TLDR
00:30 – Introduction
01:29 – Hang out: Heatwave weather and the perfect pub temperature
03:18 – Dig in: What is resilience, and how do you deal with it?
10:35 – Conversation with Benjamin Trump and Cedrick Moriggi
48:32 – Ben is a writer and Cedrick teaches children
 
Guest
Benjamin Trump: https://www.linkedin.com/in/benjamin-trump-ba062523/
Cedrick Moriggi: https://www.linkedin.com/in/cedrickmoriggi/
Hosts
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/
Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/
 
Production
Marcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
 
Sound
Ben Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/
Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/
 
'Realities Remixed' is an original podcast from Capgemini

Life sciences are at a critical inflection point, where scientific innovation, regulatory demands, and patient expectations converge with advances in data and artificial intelligence, positioning IT as a central driver of faster and more effective drug discovery and clinical development.
This week, Dave and Rob continue with part 2 off the Life Sciences mini-series with Dr. Alex Zhavoronkov founder and CEO of Insilico Medicine to exploring how drug discovery and clinical development can become faster and more effective, and the role of AI in that process. 
 
TLDR
00:40 – Introduction
01:00 – Hang out: Kill Bill Vol. 1 & 2
03:07 – Dig in: Life Sciences mini-series, Part 2
06:43 – Conversation with Dr Alex Zhavoronkov
42:12 – The future of AI in drug discovery and a new paradigm for pharma
 
Guest
Dr. Alex Zhavoronkov: https://www.linkedin.com/in/zhavoronkov/
 
Hosts
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/
Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/
 
Production
Marcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
 
Sound
Ben Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/
Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/
 
'Realities Remixed' is an original podcast from Capgemini

Innovation isn’t about funding, it’s about how organisations are built and led. Progress comes from cutting bureaucracy, empowering mission-led teams, and asking the right questions to unlock bold breakthroughs.
 
This week, Dave, Esmee and Rob are joined again by André Loesekrug-Pietri, Chair and Scientific Director of the Joint European Disruptive Initiative (JEDI, Europe’s ARPA) to explore how Europe can turn moonshot ambitions into reality by building the right people, culture and operating models for future-shaping organisations.
 
TLDR
00:41 – Introduction
01:14 – Hang out: Esmee returns and the missing API has been found!
05:14 – Dig in: Staying in step with global innovation
12:57 – Conversation with André Loesekrug-Pietri
1:02:26 – Roland Garros tennis, and unlocking creative energy
 
Guest
Andre Loeskrug-Petri: https://www.linkedin.com/in/andrepietri/
X: @eurojedi
www.jedi.foundation
 
Hosts
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/
Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/
 
Production
Marcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/
Dave Chapman:  https://www.linkedin.com/in/chapmandr/
 
Sound
Ben Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/
Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/
 
'Realities Remixed' is an original podcast from Capgemini